Galenisys Insights
GhostA monthly pharma newsletter from consultancy Galenisys mixing first-person war stories from GMP auditing and quality work with short pieces on industry trends such as GLP-1 drugs and orexins. Readers get practical quality, contamination control and project management lessons alongside light market commentary.